SITC 2022 Supporters

SITC gratefully acknowledges the following supporters of the society's 37th Annual Meeting & Pre-Conference Programs.

37th Annual Meeting

Platinum

Amgen
Bristol Myers Squibb
Incyte Corporation

Gold

Sanofi US Services, Inc.

Silver

AbbVie
Exelixis, Inc. (Commercial)
Merck Sharp & Dohme, Corp., a subsidiary of Merck & Co., Inc.

Bronze

Iovance Biotherapeutics
Pfizer, Inc.

Combination Therapy: Applying Learnings from Past Successes and Failures to Future Treatments (SITC Workshop)

Silver

Bristol Myers Squibb
Incyte Corporation
Merck Sharp & Dohme, Corp., a subsidiary of Merck & Co., Inc.

Bronze

Alkermes, Inc.

Combination Therapy: Using Novel Approaches to Identify Novel Biomarkers, Inform Patient Selection, and Design Trials

Gold

Bristol Myers Squibb
Merck Sharp & Dohme, Corp., a subsidiary of Merck & Co., Inc.

Supporters as of July 21, 2022